ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,713Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 1111

$739K Total Retail Price of All Prescriptions

Rank: 95 out of 1111

371 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 371 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 371 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 9,822 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
FUROSEMIDE 402 361 1 6
SIMVASTATIN 392 348 2 5
HYDROCODONE-ACETAMINOPHEN 313 261 S3 3 1
POTASSIUM CHLORIDE 303 263 4 9
LEVOTHYROXINE SODIUM 275 237 5 3
GABAPENTIN 259 216 6 10
WARFARIN SODIUM 243 242 7 19
ATORVASTATIN CALCIUM 236 211 8 15
OMEPRAZOLE 233 196 9 4
ROPINIROLE HCL 225 151 10 68
CARVEDILOL 214 166 11 21
METOPROLOL SUCCINATE 173 143 12 20
AMLODIPINE BESYLATE 168 164 13 7
CLOPIDOGREL 162 144 14 30
TRAMADOL HCL 154 121 15 13
CRESTOR 153 126 16 33
MELOXICAM 144 112 17 18
AZITHROMYCIN 143 117 18 39
METHYLPREDNISOLONE 132 104 19 93
LISINOPRIL 128 96 20 2
JANUVIA 127 96 21 75
ZOLPIDEM TARTRATE 126 100 22 16
CAPTOPRIL 124 115 23 240
LOSARTAN POTASSIUM 121 96 24 34
METOPROLOL TARTRATE 115 88 25 12
CITALOPRAM HBR 115 101 25 14
ALLOPURINOL 115 102 25 36
PLAVIX 107 94 28 49
METFORMIN HCL 106 86 29 8
PANTOPRAZOLE SODIUM 104 103 30 50
LEVOFLOXACIN 103 81 31 88
LYRICA 101 68 32 62
DIOVAN 100 85 33 51
SPIRONOLACTONE 98 68 34 83
FLUOXETINE HCL 97 67 35 44
GLIPIZIDE 93 73 36 57
ISOSORBIDE MONONITRATE ER 91 87 37 73
LANTUS 90 79 38 46
SUCRALFATE 88 80 39 125
FLUTICASONE PROPIONATE 80 58 40 27
NAMENDA 80 80 40 31
BUPROPION HCL SR 79 65 42 150
MIDODRINE HCL 78 67 43 268
ATENOLOL 73 72 44 22
PREDNISONE 73 62 44 48
GLIPIZIDE ER 72 72 46 99
TAMSULOSIN HCL 72 57 46 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 63 46 71
NEXIUM 70 67 49 26
LOSARTAN-HYDROCHLOROTHIAZIDE 70 58 49 72
BUSPIRONE HCL 68 47 51 96
ALENDRONATE SODIUM 65 43 52 35
HYDROCHLOROTHIAZIDE 65 63 52 11
JANUMET 65 57 52 174
DONEPEZIL HCL 63 63 55 25
CYCLOBENZAPRINE HCL 62 56 R 56 37
KLOR-CON M20 58 50 57 79
DIGOXIN 55 40 58 47
AMOXICILLIN 55 44 58 131
AMIODARONE HCL 54 53 60 145
CELEBREX 54 51 60 81
RAMIPRIL 52 52 62 168
POLYETHYLENE GLYCOL 3350 52 51 62 45
GLIPIZIDE XL 51 51 64 211
SINGULAIR 50 40 65 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.